BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3829982)

  • 1. Protective effect of latamoxef on aminoglycoside nephrotoxicity in rats.
    Kojima R; Ito M; Suzuki Y
    Dev Toxicol Environ Sci; 1986; 14():31-4. PubMed ID: 3829982
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (3). Protective effect of latamoxef against tobramycin nephrotoxicity and its protective mechanism.
    Kojima R; Ito M; Suzuki Y
    Jpn J Pharmacol; 1986 Nov; 42(3):397-404. PubMed ID: 3820859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (4). Effects of tobramycin alone and in combination with latamoxef on the stability of rat kidney lysosomal membranes.
    Kojima R; Ito M; Suzuki Y
    Jpn J Pharmacol; 1987 Jan; 43(1):73-80. PubMed ID: 3573418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the sensitivity of Fischer and Sprague-Dawley rats to aminoglycoside nephrotoxicity.
    Reinhard MK; Hottendorf GH; Powell ED
    Toxicol Pathol; 1991; 19(1):66-71. PubMed ID: 2047709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (7): Effect of latamoxef on binding of tobramycin to brush border membranes isolated from rat kidney cortex.
    Kojima R; Ito M; Suzuki Y
    Jpn J Pharmacol; 1989 Dec; 51(4):465-73. PubMed ID: 2615039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (6): A mechanism for the suppressive action of latamoxef on intrarenal tobramycin level.
    Kojima R; Ito M; Suzuki Y
    Jpn J Pharmacol; 1990 May; 53(1):111-20. PubMed ID: 2352376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects. (5). Interaction of tobramycin with latamoxef in vitro.
    Kojima R; Ito M; Suzuki Y
    J Pharmacobiodyn; 1988 Jan; 11(1):9-17. PubMed ID: 3385606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside nephrotoxicity in dogs: dependence on drug, dose and regimen.
    Thompson WL; Powell S
    Scand J Infect Dis Suppl; 1980; Suppl 23():91-5. PubMed ID: 6937972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (9): Protective effect of inositol hexasulfate against tobramycin-induced nephrotoxicity.
    Kojima R; Ito M; Suzuki Y
    Jpn J Pharmacol; 1990 Jul; 53(3):347-58. PubMed ID: 2391766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxicity of lysine and of a single dose of aminoglycoside in rats given lysine.
    Malis CD; Racusen LC; Solez K; Whelton A
    J Lab Clin Med; 1984 May; 103(5):660-76. PubMed ID: 6425441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal brush border membrane vesicle aminoglycoside binding and nephrotoxicity.
    Todd JH; Hottendorf GH
    J Pharmacol Exp Ther; 1995 Jul; 274(1):258-63. PubMed ID: 7616406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dietary n-3 and n-6 fatty acids on tobramycin induced nephrotoxicity.
    Sheema MK; Bano B
    Indian J Exp Biol; 2004 Jul; 42(7):691-7. PubMed ID: 15339034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside accumulation in the second compartment of kidney cell.
    Fujita K
    Dev Toxicol Environ Sci; 1986; 14():101-4. PubMed ID: 3829967
    [No Abstract]   [Full Text] [Related]  

  • 14. [Functional, histological, biochemical renal modifications. Comparative study of dibekacin, gentamicin, tobramycin, netilmicin and amikacin].
    Viotte G; Olier B; Morin JP; Godin M
    Nouv Presse Med; 1982 Nov; 11(46):3419-25. PubMed ID: 7155850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of tobramycin binding to rat renal brush border membrane by vancomycin.
    Yano Y; Hiraoka A; Oguma T
    J Pharmacol Exp Ther; 1995 Aug; 274(2):695-9. PubMed ID: 7636730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of moxalactam and tobramycin in normal volunteers and in patients with impaired renal function.
    Aronoff GR; Brier ME; Nierste DM; Sloan RS
    J Infect Dis; 1984 Jan; 149(1):9-15. PubMed ID: 6693791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of tobramycin nephrotoxicity in young adult and aged female rats.
    Peters-Volleberg GW; Dortant PM; Speijers GJ
    Pharmacol Toxicol; 1999 Apr; 84(4):147-53. PubMed ID: 10227064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of edaravone against tobramycin-induced ototoxicity.
    Asplund MS; Lidian A; Linder B; Takumida M; Anniko M
    Acta Otolaryngol; 2009 Jan; 129(1):8-13. PubMed ID: 18607936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aminoglycoside antibiotics on cellular functions of kidney epithelial cell line (LLC-PK1): a model system for aminoglycoside nephrotoxicity.
    Hori R; Yamamoto K; Saito H; Kohno M; Inui K
    J Pharmacol Exp Ther; 1984 Sep; 230(3):724-8. PubMed ID: 6088764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spirulina attenuates cyclosporine-induced nephrotoxicity in rats.
    Khan M; Shobha JC; Mohan IK; Rao Naidu MU; Prayag A; Kutala VK
    J Appl Toxicol; 2006; 26(5):444-51. PubMed ID: 16858688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.